Kpcb Xv Associates, LLC Portfolio Holdings

Kpcb Xv Associates, LLC

  • $35.8 Million
  • Q3 2022

Kpcb Xv Associates, LLC has filed its 13F form on October 26, 2022 for Q3 2022 where it was disclosed a total value porftolio of $35.8 Million distributed in 3 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Rapt Therapeutics, Inc. with a value of $15.6M, Twilio Inc with a value of $13.1M, and Atara Biotherapeutics, Inc. with a value of $7.09M.

Examining the 13F form we can see an decrease of $18.4M in the current position value, from $54.2M to 35.8M.

Below you can find more details about Kpcb Xv Associates, LLC portfolio as well as his latest detailed transactions.

Portfolio value $35.8 Million
Healthcare: $22.7 Million
Communication Services: $13.1 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$26.1M
$15.6 Million 43.54% of portfolio
648,531
Q3 2022 Reduced 50.0%
$19.3B
$13.1 Million 36.66% of portfolio
190,047
Q1 2022 Added 1.0%
$992M
$7.09 Million 19.79% of portfolio
1,876,650
Q4 2020 New

Summary

  • Portfolio
  • No. of Stocks 3
  • Current Value $35.8 Million
  • Prior Value $54.2 Million
  • Filing
  • Period Q3 2022
  • Filing Date October 26, 2022
  • Form Type 13F-HR
  • Activity in Q3 2022
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Kpcb Xv Associates, LLC Portfolio

Follow Kpcb Xv Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kpcb Xv Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kpcb Xv Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email